JP2002012518A - Hair cosmetic - Google Patents
Hair cosmeticInfo
- Publication number
- JP2002012518A JP2002012518A JP2000193704A JP2000193704A JP2002012518A JP 2002012518 A JP2002012518 A JP 2002012518A JP 2000193704 A JP2000193704 A JP 2000193704A JP 2000193704 A JP2000193704 A JP 2000193704A JP 2002012518 A JP2002012518 A JP 2002012518A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- weight
- external preparation
- present
- hair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims description 24
- 238000002360 preparation method Methods 0.000 claims abstract description 57
- 239000004480 active ingredient Substances 0.000 claims abstract description 25
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 20
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 239000000126 substance Substances 0.000 claims description 3
- 230000003381 solubilizing effect Effects 0.000 abstract description 16
- -1 Polyoxyethylene Polymers 0.000 description 26
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 15
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 10
- 238000009472 formulation Methods 0.000 description 9
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 8
- 239000000787 lecithin Substances 0.000 description 8
- 229940067606 lecithin Drugs 0.000 description 8
- 235000010445 lecithin Nutrition 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000003779 hair growth Effects 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 4
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 4
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 4
- 150000005215 alkyl ethers Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 230000007928 solubilization Effects 0.000 description 4
- 238000005063 solubilization Methods 0.000 description 4
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 4
- 229940032091 stigmasterol Drugs 0.000 description 4
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 4
- 235000016831 stigmasterol Nutrition 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 3
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 2
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229960003632 minoxidil Drugs 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 229940035044 sorbitan monolaurate Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- MDKGKXOCJGEUJW-VIFPVBQESA-N (2s)-2-[4-(thiophene-2-carbonyl)phenyl]propanoic acid Chemical compound C1=CC([C@@H](C(O)=O)C)=CC=C1C(=O)C1=CC=CS1 MDKGKXOCJGEUJW-VIFPVBQESA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- GQQNRZHWHWHOLI-UHFFFAOYSA-N 11-(2-decyltetradecoxymethyl)tricosane Chemical compound CCCCCCCCCCCCC(CCCCCCCCCC)COCC(CCCCCCCCCC)CCCCCCCCCCCC GQQNRZHWHWHOLI-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- LGJMUZUPVCAVPU-JFBKYFIKSA-N Sitostanol Natural products O[C@@H]1C[C@H]2[C@@](C)([C@@H]3[C@@H]([C@H]4[C@@](C)([C@@H]([C@@H](CC[C@H](C(C)C)CC)C)CC4)CC3)CC2)CC1 LGJMUZUPVCAVPU-JFBKYFIKSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 150000005415 aminobenzoic acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 229960002962 butenafine Drugs 0.000 description 1
- ABJKWBDEJIDSJZ-UHFFFAOYSA-N butenafine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)CC1=CC=C(C(C)(C)C)C=C1 ABJKWBDEJIDSJZ-UHFFFAOYSA-N 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000005131 dialkylammonium group Chemical group 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 150000002061 ecdysteroids Chemical class 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 150000002339 glycosphingolipids Chemical class 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002353 niosome Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- LGJMUZUPVCAVPU-HRJGVYIJSA-N stigmastanol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]2(C)CC1 LGJMUZUPVCAVPU-HRJGVYIJSA-N 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229960004492 suprofen Drugs 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229960002722 terbinafine Drugs 0.000 description 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、化粧料に好適な皮
膚外用剤に関し、更に詳細には、水難溶性有効成分を含
有する可溶化形態の皮膚外用剤に関する。TECHNICAL FIELD The present invention relates to a skin external preparation suitable for cosmetics, and more particularly to a solubilized form of a skin external preparation containing a poorly water-soluble active ingredient.
【0002】[0002]
【従来の技術】化粧料や皮膚外用医薬などの、皮膚外用
剤の分野において、それらの有効成分の内の多くは、水
難溶性を示す。この為、皮膚外用剤の製剤化にあたって
は、これらを均一に分散或いは可溶化させることが最大
の課題となる。この様な製剤化にあたっては、この様な
水難溶性有効成分を含有させる場合には、乳液やクリー
ムなどの乳化剤形の製剤を使用するが、その製剤特性に
よっては、この様な乳化系が使用しにくい場合がある。
この様な製剤としては例えば、育毛化粧料や育毛皮膚外
用医薬等が挙げられる。これらに於いて、乳化剤形を使
用すると、毛髪がべたついたり、毛髪が油性成分で濡れ
薄毛等の状況がかえって目立つ様な好ましくない状況が
出現することがあり、この様な製剤特性のものには、可
溶化剤形系を工夫して使用するしかなかった。しかしな
がら、この様な可溶化系においては、有効成分の可溶化
量には制限があり、更なる可溶化手段の改善が望まれて
いた。更に近年に於いては、可溶化助剤として使用して
いるエタノールの使用量にも、環境保全の見地から制限
される傾向にあり、少量のエタノール含有系での可溶化
手段の改善が望まれていた。この様な改善は、ヘアトニ
ックなどのエタノールの含有量が多かった系では、特に
如実であった。2. Description of the Related Art In the field of external preparations for skin such as cosmetics and external preparations for skin, many of those active ingredients have poor water solubility. For this reason, in formulating skin external preparations, the greatest challenge is to uniformly disperse or solubilize them. In preparing such a formulation, when such a poorly water-soluble active ingredient is contained, an emulsified formulation such as an emulsion or cream is used, but depending on the formulation characteristics, such an emulsified system may be used. It may be difficult.
Examples of such preparations include hair growth cosmetics and hair growth skin external medicine. In these, when the emulsifying agent form is used, the hair may become sticky, or the hair may be wet with an oily component. However, there has been no choice but to use a solubilizing agent type system. However, in such a solubilizing system, the amount of the active ingredient solubilized is limited, and further improvement of the solubilizing means has been desired. Furthermore, in recent years, the amount of ethanol used as a solubilizing aid has also tended to be limited from the viewpoint of environmental conservation, and it is desired to improve solubilizing means with a small amount of ethanol-containing system. I was This improvement was particularly evident in systems with a high ethanol content, such as hair tonics.
【0003】一方、可溶化形態の皮膚外用剤に於いて、
水難溶性の有効成分と非イオン界面活性剤と燐脂質とを
含有する様な製剤は全く知られていなかった。On the other hand, in a solubilized form of a skin external preparation,
No formulation containing a poorly water-soluble active ingredient, a nonionic surfactant and a phospholipid has been known at all.
【0004】[0004]
【発明が解決しようとする課題】本発明は、この様な状
況下為されたものであり、可溶化形態の皮膚外用剤取り
分け毛髪用の皮膚外用剤に於いて、水難溶性有効成分の
新規の可溶化手段を提供することを課題とする。DISCLOSURE OF THE INVENTION The present invention has been made under such circumstances, and in a solubilized form of a skin external preparation, a novel water-insoluble active ingredient for a skin external preparation for hair. It is an object to provide a solubilizing means.
【0005】[0005]
【課題の解決手段】本発明者らは、この様な状況に鑑み
て、可溶化形態の皮膚外用剤取り分け毛髪用の皮膚外用
剤に於いて、水難溶性有効成分の新規の可溶化手段を求
めて、鋭意研究努力を重ねた結果、皮膚外用剤に水難溶
性の有効成分と非イオン界面活性剤と燐脂質とを含有さ
せることにより、この様な可溶化が為し得ることを見い
だし、発明を完成させるに至った。即ち、本発明は以下
に示す技術に関するものである。 (1)水難溶性の有効成分と非イオン界面活性剤と燐脂
質とを含有することを特徴とする、可溶化形態の皮膚外
用剤。 (2)エタノールの含有量が40重量%以下であること
を特徴とする、(1)に記載の皮膚外用剤。 (3)非イオン界面活性剤の含有量が、1重量%以下で
あることを特徴とする、(1)又は(2)に記載の皮膚
外用剤。 (4)水難溶性物質が育毛剤であることを特徴とする、
(1)〜(3)何れか一項に記載の皮膚外用剤。 (5)化粧料であることを特徴とする、(1)〜(4)
何れか一項に記載の皮膚外用剤。 (6)毛髪用であることを特徴とする、(1)〜(5)
何れか一項に記載の皮膚外用剤。 以下、本発明について、実施の形態を中心に詳細に説明
を加える。In view of such circumstances, the present inventors have sought a new means for solubilizing a poorly water-soluble active ingredient in a skin external preparation, particularly for a solubilized form of a skin external preparation. As a result of diligent research efforts, they have found that such a solubilization can be achieved by adding a poorly water-soluble active ingredient, a nonionic surfactant and a phospholipid to a skin external preparation, and have developed the invention. It was completed. That is, the present invention relates to the following technology. (1) A solubilized form of a skin external preparation comprising a sparingly water-soluble active ingredient, a nonionic surfactant and a phospholipid. (2) The skin external preparation according to (1), wherein the content of ethanol is 40% by weight or less. (3) The skin external preparation according to (1) or (2), wherein the content of the nonionic surfactant is 1% by weight or less. (4) the poorly water-soluble substance is a hair restorer;
(1) The external preparation for skin according to any one of (1) to (3). (5) (1) to (4) characterized by being a cosmetic.
An external preparation for skin according to any one of the preceding claims. (6) (1) to (5) characterized by being for hair
An external preparation for skin according to any one of the preceding claims. Hereinafter, the present invention will be described in detail focusing on embodiments.
【0006】[0006]
【発明の実施の形態】(1)本発明の皮膚外用剤の必須
成分である燐脂質 本発明の皮膚外用剤は燐脂質を必須成分として含有する
ことを特徴とする。本発明の皮膚外用剤で使用できる燐
脂質としては、皮膚外用剤で通常使用されているもので
あれば、特段の限定無く使用することができ、例えば、
レシチン、ホスファチジルセリン、ホスファチジルイノ
シトール、ホスファチジルグリセロール及びこれらのリ
ゾ体が好ましく例示できる。これらは唯一種でも、二種
以上を組み合わせて使用しても良い。この中でも特に好
ましいものは、使用実績の多いレシチンである。レシチ
ンの起源は大豆のような植物であっても、卵黄の様な動
物であってもかまわない。本発明の皮膚外用剤に於い
て、これら燐脂質は、後記非イオン界面活性剤とともに
働き、水難溶性有効成分を可溶化させる作用を有する。
ここで、本発明で言う可溶化とは、光を散乱しない小さ
なミセルを形成し、透明な外観を有する一相の系を形成
することを意味し、リポソームやニオソーム等の製剤を
含まない。本発明の皮膚外用剤に於ける、これら燐脂質
の好ましい含有量は、皮膚外用剤全量に対して0.05
〜2重量%が好ましく、更に好ましくは0.1〜1重量
%である。これは、燐脂質量が多すぎると、可溶化域を
逸脱する場合があり、少なすぎると可溶化できない場合
があるからである。DESCRIPTION OF THE PREFERRED EMBODIMENTS (1) Phospholipid as an essential component of the external preparation for skin of the present invention The external preparation for skin of the present invention is characterized by containing a phospholipid as an essential component. The phospholipids that can be used in the external preparation for skin of the present invention can be used without any particular limitation as long as they are usually used in external preparations for skin.
Preferred examples thereof include lecithin, phosphatidylserine, phosphatidylinositol, phosphatidylglycerol, and lyso forms thereof. These may be used alone or in combination of two or more. Among them, particularly preferred is lecithin which has been used frequently. Lecithin may originate from a plant like soybeans or from an animal like egg yolk. In the skin external preparation of the present invention, these phospholipids work together with a nonionic surfactant described later, and have an action of solubilizing a poorly water-soluble active ingredient.
Here, solubilization in the present invention means forming small micelles that do not scatter light and forming a one-phase system having a transparent appearance, and does not include preparations such as liposomes and niosomes. The preferred content of these phospholipids in the skin external preparation of the present invention is 0.05 to the total amount of the skin external preparation.
To 2% by weight, more preferably 0.1 to 1% by weight. This is because if the amount of the phospholipid is too large, it may deviate from the solubilization zone, and if it is too small, the solubilization may not be possible.
【0007】(2)本発明の皮膚外用剤の必須成分であ
る非イオン界面活性剤 本発明の皮膚外用剤は、非イオン界面活性剤を含有する
ことも特徴とする。ここで、本発明の皮膚外用剤で使用
できる非イオン界面活性剤としては、HLBが10〜2
0の親水性の非イオン界面活性剤が好ましく、例えば、
ポリオキシエチレンアルキルエーテル、ポリオキシエチ
レン脂肪酸エステル、ポリオキシエチレンポリオキシプ
ロピレンアルキルエーテル、ポリオキシエチレンポリオ
キシプロピレン脂肪酸エステル、ポリオキシエチレン硬
化ひまし油、ポリオキシエチレンひまし油、ポリオキシ
エチレンポリオキシプロピレンアルキルエーテル、ソル
ビタン脂肪酸エステル等が好ましく例示できる。これら
の内、特に好ましいものは、ポリオキシエチレン・ポリ
オキシプロピレン−2−デシルテトラデシルエーテル、
ポリオキシエチレンフィトスタノール、ソルビタンモノ
ラウレートである。アルキレンオキサイドの付加モル数
まで加味すれば、ポリオキシエチレン(20)ポリオキ
シプロピレン(6)−2−デシルテトラデシルエーテ
ル、ポリオキシエチレン(5)フィトスタノール、ポリ
オキシエチレン(10)フィトスタノールが好ましく例
示できる。これら非イオン界面活性剤は唯一種を含有す
ることもできるし、二種以上を組み合わせて含有させる
こともできる。本発明の皮膚外用剤に於ける、これら非
イオン界面活性剤の好ましい含有量は、0.05〜2重
量%であり、更に好ましくは0.1〜1重量%である。
これは少なすぎると可溶化できないし、多すぎても効果
が頭打ちになり、使用感を損なうことがあるからであ
る。特に非イオン界面活性剤は安全性の面から勘案する
と1重量%以下であることは特に好ましい。(2) Nonionic surfactant which is an essential component of the external preparation for skin of the present invention The external preparation for skin of the present invention is also characterized by containing a nonionic surfactant. Here, as the nonionic surfactant that can be used in the skin external preparation of the present invention, HLB is 10 to 2
A hydrophilic nonionic surfactant of 0 is preferred, for example,
Polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene polyoxypropylene fatty acid ester, polyoxyethylene hardened castor oil, polyoxyethylene castor oil, polyoxyethylene polyoxypropylene alkyl ether, Preferred examples include sorbitan fatty acid esters. Of these, particularly preferred are polyoxyethylene / polyoxypropylene-2-decyltetradecyl ether,
Polyoxyethylene phytostanol and sorbitan monolaurate. Taking into account the addition mole number of the alkylene oxide, polyoxyethylene (20) polyoxypropylene (6) -2-decyltetradecyl ether, polyoxyethylene (5) phytostanol, and polyoxyethylene (10) phytostanol are preferable. Can be illustrated. These nonionic surfactants may contain only one kind, or may contain two or more kinds in combination. The preferred content of these nonionic surfactants in the skin external preparation of the present invention is 0.05 to 2% by weight, more preferably 0.1 to 1% by weight.
This is because if it is too small, it cannot be solubilized, and if it is too large, the effect will reach a plateau and the feeling of use may be impaired. In particular, the content of the nonionic surfactant is particularly preferably 1% by weight or less from the viewpoint of safety.
【0008】(3)本発明の皮膚外用剤の必須成分であ
る水難溶性の有効成分 本発明の皮膚外用剤は、水難溶性有効成分を含有するこ
とも特徴とする。ここで、本発明で言う水難溶性とは、
水に対する溶解度が0.01重量%以下の溶性を示す成
分を言う。かかる有効成分の有する効能としては、例え
ば、フィトステサイド類、スフィンゴ糖脂質、スフィン
ゴ燐脂質類等による保湿作用或いは肌保護作用、パラベ
ン類等の防腐剤やテルビナフィンやブテナフィン等の抗
真菌剤による抗菌作用或いは防腐作用、ステロイド類や
インドメタシン、スプロフェンなどの抗炎症剤による抗
炎症作用或いは鎮痛作用、ミノキシジルやフィトステサ
イドなどの育毛剤による育毛作用、ウィッチヘーゼル等
の薬用植物の抽出物などによる収斂作用、ベンゾフェノ
ン類や桂皮酸エステル、アミノ安息香酸エステル類など
の紫外線吸収剤による紫外線吸収作用などが例示でき、
これらの内では、育毛作用を有する有効成分が特に好適
である。これは、育毛用の皮膚化粧料が、使用感や使用
勝手などのその製剤特性から、可溶化系で用いられるこ
とが特に多いからである。具体的な育毛用の有効成分と
しては、例えば、ミノキシジル、フィトステサイド、ニ
コチン酸トコフェロール、エチニルエストラジオール、
ポリポルステロン、エクジステロイド類等が好ましく例
示できる。この内、フィトステサイドが特に好ましく、
フィトステサイドとして特に好ましいものは、スティグ
マステロールやスティグマスタノールの配糖体であり、
中でもスティグマステロールマルトシドやスティグマス
タノールマルトシドが好ましく、スティグマスタノール
マルトシドが特に好ましい。これらの有効成分の本発明
の化粧料に於ける、含有量は、その有効量によって決定
されれば良いが、大凡、0.01〜1重量%が好まし
い。(3) Poorly water-soluble active ingredient, which is an essential component of the skin external preparation of the present invention, is also characterized in that it contains a poorly water-soluble active ingredient. Here, the term "poorly water-soluble" in the present invention means:
A component having a solubility in water of 0.01% by weight or less. The effects of such active ingredients include, for example, phytostesides, glycosphingolipids, moisturizing action or skin protecting action by sphingolipids, antibacterial by preservatives such as parabens and antifungal agents such as terbinafine and butenafine. Action or antiseptic action, anti-inflammatory action or analgesic action by anti-inflammatory agents such as steroids, indomethacin, and suprofen; hair-growth action by hair restorer such as minoxidil and phytosteide; astringent action by medicinal plant extracts such as witch hazel , Benzophenones and cinnamic acid esters, such as UV-absorbing action of UV-absorbing agents such as aminobenzoic acid esters,
Of these, active ingredients having a hair-growth effect are particularly preferred. This is because the skin cosmetic for hair growth is particularly often used in a solubilizing system due to its formulation characteristics such as feeling of use and ease of use. Specific active ingredients for hair growth include, for example, minoxidil, phytosteide, tocopherol nicotinate, ethinylestradiol,
Preferred examples include polyporsterone and ecdysteroids. Of these, phytosteide is particularly preferred,
Particularly preferred as phytosteside are glycosides of stigmasterol and stigmasterol,
Among them, stigmasterol maltoside and stigmasteranol maltoside are preferable, and stigmasterol maltoside is particularly preferable. The content of these active ingredients in the cosmetic of the present invention may be determined by the effective amount, but is preferably about 0.01 to 1% by weight.
【0009】(4)本発明の皮膚外用剤 本発明の皮膚外用剤は、上記の必須成分である、水難溶
性の有効成分と非イオン界面活性剤と燐脂質とを含有
し、可溶化剤形であることを特徴とする。ここで、本発
明で言う皮膚外用剤とは、皮膚に経皮的に投与する形態
の組成物の総称で、具体的には、化粧料、皮膚外用医
薬、皮膚の殺菌・消毒剤などが例示できる。これらの
内、特に好ましいものは化粧料である。これは、化粧料
に於いては、エタノールなどの溶媒の使用量にある程度
の制限があり、しかも剤形的に可溶化剤形が多く、水難
溶性の有効成分が多種含有されるケースが多いためであ
り、この様な状況から、従来に於いては、可溶化剤形で
結晶や油状物質が経時的に析出するトラブルが少なくな
かったからである。この様なトラブルは、本発明の技術
を適用することにより、大きく改善でき、本発明の効果
が充分に生かせる素地があるからである。この様な化粧
料の中に於いては、本発明の皮膚外用剤は、有効成分と
して、育毛剤を可溶化した、毛髪用の化粧料に適用する
ことが好ましい。これは、この様な毛髪用の化粧料に於
いて、環境科学的な見地から、エタノールの使用量を制
限する傾向にあり、前記可溶化手段が、近年特に強く求
められているからである。(4) External preparation for skin of the present invention The external preparation for skin of the present invention comprises the above-mentioned essential ingredients, a poorly water-soluble active ingredient, a nonionic surfactant and a phospholipid, and is a solubilizing agent. It is characterized by being. Here, the external preparation for skin referred to in the present invention is a general term for a composition in the form of percutaneous administration to the skin, and specific examples thereof include cosmetics, external skin medicines, and disinfectants and disinfectants for skin. it can. Of these, cosmetics are particularly preferred. This is because, in cosmetics, the amount of solvent such as ethanol is limited to some extent, moreover, there are many solubilizers in dosage form, and many cases contain many types of poorly water-soluble active ingredients. Under such circumstances, there have been many troubles in which crystals and oily substances are precipitated with time in the form of a solubilizing agent. This is because such a trouble can be greatly improved by applying the technology of the present invention, and there is a base material that can fully utilize the effects of the present invention. In such cosmetics, the external preparation for skin of the present invention is preferably applied as an active ingredient to a cosmetic for hair in which a hair restorer is solubilized. This is because, in such hair cosmetics, the amount of ethanol used tends to be restricted from the viewpoint of environmental science, and the solubilizing means is particularly strongly required in recent years.
【0010】本発明の皮膚外用剤に於いては、上記の必
須成分以外に、通常皮膚外用剤で使用される任意の成分
を含有することができる。この様な任意の成分として
は、例えば、スクワラン、ワセリン、マイクロクリスタ
リンワックス等の炭化水素類、ホホバ油、カルナウバワ
ックス,オレイン酸オクチルドデシル等のエステル類、
オリーブ油、牛脂、椰子油等のトリグリセライド類、ス
テアリン酸、オレイン酸、リチノレイン酸等の脂肪酸、
オレイルアルコール、ステアリルアルコール、オクチル
ドデカノール等の高級アルコール、スルホコハク酸エス
テルやポリオキシエチレンアルキル硫酸ナトリウム等の
アニオン界面活性剤類、アルキルベタイン塩等の両性界
面活性剤類、ジアルキルアンモニウム塩等のカチオン界
面活性剤類、ソルビタン脂肪酸エステル、脂肪酸モノグ
リセライド、これらのポリオキシエチレン付加物、ポリ
オキシエチレンアルキルエーテル、ポリオキシエチレン
脂肪酸エステル等の非イオン界面活性剤類、ポリエチレ
ングリコール、グリセリン、1,3−ブタンジオール等
の多価アルコール類、増粘・ゲル化剤、酸化防止剤、紫
外線吸収剤、色剤、防腐剤、粉体等を好ましく例示でき
る。これら必須成分と任意成分とを常法に従って処理す
ることにより、本発明の皮膚外用剤は製造できる。The external preparation for skin of the present invention may contain, in addition to the above-mentioned essential components, any components usually used in external preparations for skin. Such optional components include, for example, hydrocarbons such as squalane, petrolatum, and microcrystalline wax, jojoba oil, carnauba wax, esters such as octyldodecyl oleate,
Triglycerides such as olive oil, beef tallow, and coconut oil; fatty acids such as stearic acid, oleic acid, and ritinoleic acid;
Higher alcohols such as oleyl alcohol, stearyl alcohol and octyl dodecanol; anionic surfactants such as sulfosuccinates and sodium polyoxyethylene alkyl sulfate; amphoteric surfactants such as alkyl betaine salts; cationic interfaces such as dialkyl ammonium salts. Activators, sorbitan fatty acid esters, fatty acid monoglycerides, nonionic surfactants such as polyoxyethylene adducts, polyoxyethylene alkyl ethers, polyoxyethylene fatty acid esters, etc., polyethylene glycol, glycerin, 1,3-butanediol And the like, polyhydric alcohols such as, for example, thickening / gelling agents, antioxidants, ultraviolet absorbers, coloring agents, preservatives, and powders. The external preparation for skin of the present invention can be produced by treating these essential components and optional components according to a conventional method.
【0011】[0011]
【実施例】以下に、実施例を挙げて、本発明について更
に詳細に説明を加えるが、本発明がかかる実施例にのみ
限定されないことは言うまでもない。EXAMPLES Hereinafter, the present invention will be described in more detail with reference to Examples, but it goes without saying that the present invention is not limited to only these Examples.
【0012】<実施例1〜3>以下に示す処方に従っ
て、本発明の皮膚外用剤である、毛髪用の化粧料を作製
した。即ち、処方成分を80℃で攪拌可溶化し、攪拌冷
却して化粧料を得た。このものを1週間5℃、20℃、
40℃に保存し可溶化状態を観察した。観察の基準は、
○:異常なし、△:僅かな濁り又は結晶の析出、×:明
らかな濁り又は結晶の析出を用いた。又、専門パネラー
により、使用感も調べた。使用感の項目は「べたつきの
なさ」と「使用後の脂っぽさのなさ」であり、○:良
い、△:やや難あり、×:悪いであった。比較例1は燐
脂質(レシチン)のみ、比較例2は非イオン界面活性剤
(ポリオキシエチレン(10)フィトスタノール;BP
SH10)のみのものを用いた。結果を表1に示す。こ
れより、本発明の皮膚外用剤である、毛髪用の化粧料は
優れた可溶化特性と使用感とを有することがわかる。
又、エタノールの含有量が20重量%低いにも関わら
ず、この様な優れた特性を有していることについても注
目すべきである。 スティグマスタノールマルトシド 0.1重量部 燐脂質/非イオン界面活性剤* 1 重量部 1,3−ブタンジオール 5 重量部 メチルパラベン 0.1重量部 エタノール 20 重量部 水 73.8重量部 *詳細は表1に示す。<Examples 1 to 3> Cosmetics for hair, which is an external preparation for skin of the present invention, were prepared according to the following formulations. That is, the ingredients were stirred and solubilized at 80 ° C., and cooled by stirring to obtain a cosmetic. This is one week at 5 ℃, 20 ℃,
After storage at 40 ° C., the solubilized state was observed. The standard of observation is
:: no abnormality, Δ: slight turbidity or precipitation of crystals, x: clear turbidity or precipitation of crystals. The feeling of use was also examined by a specialized panelist. The items of feeling of use were "non-stickiness" and "non-greasy after use", and were ○: good, Δ: slightly difficult, and ×: bad. Comparative Example 1 contained only a phospholipid (lecithin) and Comparative Example 2 contained a nonionic surfactant (polyoxyethylene (10) phytostanol; BP
SH10) alone. Table 1 shows the results. This indicates that the cosmetic for hair, which is an external preparation for skin of the present invention, has excellent solubilizing properties and a feeling of use.
It should also be noted that despite the low ethanol content of 20% by weight, it has such excellent properties. Stigmatanol maltoside 0.1 part by weight Phospholipid / nonionic surfactant * 1 part by weight 1,3-butanediol 5 parts by weight Methyl paraben 0.1 part by weight Ethanol 20 parts by weight Water 73.8 parts by weight * Details in the table It is shown in FIG.
【0013】[0013]
【表1】 [Table 1]
【0014】<実施例4〜8>以下に示す処方に従っ
て、本発明の皮膚外用剤である、毛髪用の化粧料を作製
した。即ち、処方成分を80℃で攪拌可溶化し、攪拌冷
却して化粧料を得た。このものを実施例1〜3と同様に
評価した。結果を表2に示す。これより、本発明の皮膚
外用剤である、毛髪用の化粧料は優れた可溶化特性と使
用感とを有することがわかる。又、エタノールの含有量
が20重量%低いにも関わらず、この様な優れた特性を
有していることについても注目すべきである。 スティグマスタノールマルトシド 0.1重量部 レシチン 0.5重量部 非イオン界面活性剤** 0.5重量部 1,3−ブタンジオール 5 重量部 メチルパラベン 0.1重量部 エタノール 20 重量部 水 73.8重量部 **詳細は表2に記す。<Examples 4 to 8> Cosmetics for hair, which is an external preparation for skin of the present invention, were prepared according to the following formulations. That is, the ingredients were stirred and solubilized at 80 ° C., and cooled by stirring to obtain a cosmetic. This was evaluated in the same manner as in Examples 1 to 3. Table 2 shows the results. This indicates that the cosmetic for hair, which is an external preparation for skin of the present invention, has excellent solubilizing properties and a feeling of use. It should also be noted that despite the low ethanol content of 20% by weight, it has such excellent properties. Stigmasteranol maltoside 0.1 part by weight Lecithin 0.5 part by weight Nonionic surfactant ** 0.5 part by weight 1,3-butanediol 5 parts by weight Methylparaben 0.1 part by weight Ethanol 20 parts by weight Water 73.8 Parts by weight ** Details are shown in Table 2.
【0015】[0015]
【表2】 [Table 2]
【0016】<実施例9〜12>以下に示す処方に従っ
て、本発明の皮膚外用剤である、皮膚用の化粧料を作製
した。即ち、処方成分を80℃で攪拌可溶化し、攪拌冷
却して化粧料を得た。このものを実施例1〜3と同様に
安定性のみを評価した。結果を表3に示す。これより、
本発明の皮膚外用剤である、皮膚用の化粧料は優れた可
溶化特性を有することがわかる。又、エタノール含有し
ないにも関わらず、この様な優れた特性を有しているこ
とについても注目すべきである。 有効成分*** 0.1重量部 レシチン 0.5重量部 POE(10)フィトスタノール 0.5重量部 1,3−ブタンジオール 5 重量部 グリセリン 5 重量部 1,2−ペンタンジオール 5 重量部 メチルパラベン 0.1重量部 水 83.8重量部 ***詳細は表3に記す。<Examples 9 to 12> Cosmetic products for skin, which are external preparations for skin of the present invention, were prepared according to the following formulations. That is, the ingredients were stirred and solubilized at 80 ° C., and cooled by stirring to obtain a cosmetic. This was evaluated for stability only in the same manner as in Examples 1 to 3. Table 3 shows the results. Than this,
It can be seen that the cosmetic for skin, which is an external preparation for skin of the present invention, has excellent solubilizing properties. It should also be noted that despite having no ethanol, it has such excellent properties. Active ingredient *** 0.1 parts by weight Lecithin 0.5 parts by weight POE (10) phytostanol 0.5 parts by weight 1,3-butanediol 5 parts by weight Glycerin 5 parts by weight 1,2-pentanediol 5 parts by weight Methylparaben 0.1 parts by weight Water 83.8 parts by weight *** Details are shown in Table 3.
【0017】[0017]
【表3】 [Table 3]
【0018】<実施例13〜16>以下に示す処方に従
って、本発明の皮膚外用剤である、皮膚用の医薬組成物
を作製した。即ち、処方成分を80℃で攪拌可溶化し、
攪拌冷却して化粧料を得た。このものを実施例1〜3と
同様に安定性のみを評価した。結果を表4に示す。これ
より、本発明の皮膚外用剤である、皮膚用の医薬組成物
は優れた可溶化特性を有することがわかる。又、エタノ
ールを10重量%しか含有しないにも関わらず、この様
な優れた特性を有していることについても注目すべきで
ある。 有効成分**** 0.1重量部 レシチン 0.5重量部 POE(10)フィトスタノール 0.5重量部 1,3−ブタンジオール 5 重量部 グリセリン 5 重量部 1,2−ペンタンジオール 5 重量部 エタノール 10 重量部 メチルパラベン 0.1重量部 水 83.8重量部 ****詳細は表4に記す。<Examples 13 to 16> According to the following formulation, a skin pharmaceutical composition, which is an external preparation for skin of the present invention, was prepared. That is, the ingredients are stirred and solubilized at 80 ° C.
The cosmetic was obtained by stirring and cooling. This was evaluated for stability only in the same manner as in Examples 1 to 3. Table 4 shows the results. From this, it is understood that the pharmaceutical composition for skin, which is an external preparation for skin of the present invention, has excellent solubilizing properties. It should also be noted that despite having only 10% by weight of ethanol, it has such excellent properties. Active ingredient **** 0.1 part by weight Lecithin 0.5 part by weight POE (10) phytostanol 0.5 part by weight 1,3-butanediol 5 parts by weight Glycerin 5 parts by weight 1,2-pentanediol 5 parts by weight Ethanol 10 parts by weight Methyl paraben 0.1 parts by weight Water 83.8 parts by weight **** Details are shown in Table 4.
【0019】[0019]
【表4】 [Table 4]
【0020】<実施例17〜19>次に示す処方に従っ
て、上記同様の処理して毛髪用の化粧料を作成した。安
定性と使用感について、実施例1〜3と同様に評価した
結果を表5に示す。これらのものは、5℃、20℃、4
0℃での1ヶ月の保存条件でも極めて安定であり、その
使用感も極めて優れるものであった。 スティグマスタノールマルトシド 0.1重量部 レシチン/PEN4620***** 1 重量部 ソルビタンモノラウレート 0.2重量部 1,3−ブタンジオール 1 重量部 エタノール 30 重量部 水 67.7重量部 ******詳細は表5に示す。PEN4620はPOE(20)POP(6) 2−デシルテトラデシルエーテルを表す。<Examples 17 to 19> Cosmetics for hair were prepared according to the following recipe in the same manner as described above. Table 5 shows the results of evaluating the stability and feeling of use in the same manner as in Examples 1 to 3. These are 5 ° C, 20 ° C, 4
It was extremely stable even under the condition of storage at 0 ° C. for one month, and the feeling of use was extremely excellent. Stigmastanol maltoside 0.1 parts by weight Lecithin / PEN4620 **** 1 part by weight Sorbitan monolaurate 0.2 parts by weight 1,3-butanediol 1 part by weight Ethanol 30 parts by weight Water 67.7 parts by weight ** **** Details are shown in Table 5. PEN4620 represents POE (20) POP (6) 2-decyltetradecyl ether.
【0021】[0021]
【表5】 [Table 5]
【0022】[0022]
【発明の効果】本発明によれば、可溶化形態の皮膚外用
剤取り分け毛髪用の皮膚外用剤に於いて、水難溶性有効
成分の新規の可溶化手段を提供できる。According to the present invention, it is possible to provide a novel means for solubilizing a poorly water-soluble active ingredient in a solubilized form of a skin external preparation, especially for a skin external preparation for hair.
フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61P 17/16 A61P 17/16 // A61K 45/00 A61K 45/00 Fターム(参考) 4C076 AA11 BB31 CC05 CC18 CC30 DD09 DD37 DD38 DD45 DD63 DD69 DD70 FF15 4C083 AC101 AC102 AC112 AC122 AC442 AC482 AD391 AD491 AD571 AD572 BB04 BB53 CC01 CC31 CC37 DD23 DD27 DD38 EE22 4C084 AA17 AA27 NA02 ZA892 ZA922 Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat II (reference) A61P 17/16 A61P 17/16 // A61K 45/00 A61K 45/00 F term (reference) 4C076 AA11 BB31 CC05 CC18 CC30 DD09 DD37 DD38 DD45 DD63 DD69 DD70 FF15 4C083 AC101 AC102 AC112 AC122 AC442 AC482 AD391 AD491 AD571 AD572 BB04 BB53 CC01 CC31 CC37 DD23 DD27 DD38 EE22 4C084 AA17 AA27 NA02 ZA892 ZA922
Claims (6)
剤と燐脂質とを含有することを特徴とする、可溶化形態
の皮膚外用剤。1. A solubilized form of a skin external preparation comprising a poorly water-soluble active ingredient, a nonionic surfactant and a phospholipid.
あることを特徴とする、請求項1に記載の皮膚外用剤。2. The external preparation for skin according to claim 1, wherein the content of ethanol is 40% by weight or less.
%以下であることを特徴とする、請求項1又は2に記載
の皮膚外用剤。3. The external preparation for skin according to claim 1, wherein the content of the nonionic surfactant is 1% by weight or less.
とする、請求項1〜3何れか一項に記載の皮膚外用剤。4. The external preparation for skin according to claim 1, wherein the poorly water-soluble substance is a hair restorer.
1〜4何れか一項に記載の皮膚外用剤。5. The external preparation for skin according to claim 1, which is a cosmetic.
1〜5何れか一項に記載の皮膚外用剤。6. The external preparation for skin according to any one of claims 1 to 5, which is used for hair.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000193704A JP2002012518A (en) | 2000-06-28 | 2000-06-28 | Hair cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000193704A JP2002012518A (en) | 2000-06-28 | 2000-06-28 | Hair cosmetic |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002012518A true JP2002012518A (en) | 2002-01-15 |
JP2002012518A5 JP2002012518A5 (en) | 2007-07-19 |
Family
ID=18692648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000193704A Pending JP2002012518A (en) | 2000-06-28 | 2000-06-28 | Hair cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2002012518A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010511032A (en) * | 2006-11-29 | 2010-04-08 | マルベルン コスメセウチクス リミテッド | Composition comprising a polymer aggregate of lipid and surfactant |
WO2015136783A1 (en) * | 2014-03-14 | 2015-09-17 | 富士フイルム株式会社 | Dispersion composition and cosmetic material |
-
2000
- 2000-06-28 JP JP2000193704A patent/JP2002012518A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010511032A (en) * | 2006-11-29 | 2010-04-08 | マルベルン コスメセウチクス リミテッド | Composition comprising a polymer aggregate of lipid and surfactant |
JP2015110569A (en) * | 2006-11-29 | 2015-06-18 | マルベルン コスメセウチクス リミテッド | Compositions comprising macromolecular assemblies of lipid and surfactant |
JP2017105808A (en) * | 2006-11-29 | 2017-06-15 | マルベルン コスメセウチクス リミテッド | Compositions comprising macromolecular assemblies of lipid and surfactant |
WO2015136783A1 (en) * | 2014-03-14 | 2015-09-17 | 富士フイルム株式会社 | Dispersion composition and cosmetic material |
CN106132391A (en) * | 2014-03-14 | 2016-11-16 | 富士胶片株式会社 | Dispersive composition and cosmetics |
JPWO2015136783A1 (en) * | 2014-03-14 | 2017-04-06 | 富士フイルム株式会社 | Dispersion composition and cosmetics |
CN106132391B (en) * | 2014-03-14 | 2019-05-14 | 富士胶片株式会社 | Dispersive composition and cosmetics |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100369258B1 (en) | Nanoemulsion based on oxyethylenated or non-oxyethylenated sorbitan fatty esters, and its uses in the cosmetics, dermatological and/or ophthalmological fields | |
JP3888470B2 (en) | Skin protective composition containing emulsified petrolatum | |
EP1267830B1 (en) | Method for preparing high pressure/high shear dispersions containing physiologically active ingredients | |
JPH0336567B2 (en) | ||
JP5623076B2 (en) | Vesicle composition and external preparation for skin | |
JP4049216B2 (en) | Formulation with liquid crystal structure | |
JP4700150B2 (en) | Solubilized composition | |
JP2002326920A (en) | Emulsion composition | |
JPS63126542A (en) | Microemulsion | |
US5567419A (en) | Stabilized cosmetic compositions containing monoacyl phosphatide and a saponin | |
JPH0613448B2 (en) | Cutaneous elastic fibrosis preventive agent | |
JP2001163766A (en) | Composition containing pentacyclic triterpenic acid, particularly cosmetic composition | |
EP0375082A2 (en) | Cosmetic composition | |
TW200916118A (en) | External preparation for skin | |
JP4099112B2 (en) | Emulsified / solubilized skin external preparation | |
JP4430889B2 (en) | Preparations for topical skin containing sparingly soluble materials | |
JP2002012518A (en) | Hair cosmetic | |
JP3568983B2 (en) | Hair restorer | |
JP3308555B2 (en) | Method for producing finely divided emulsion composition | |
JP2003267830A (en) | Liquid cosmetic | |
JP3441387B2 (en) | Moisturizer, skin cosmetics and bath additives | |
JP2004346039A (en) | Emulsified composition | |
JP2000001416A (en) | Polyol-containing liposome | |
JP3712673B2 (en) | Gel composition and oil-in-water (O / W) type composition | |
JP2000239157A (en) | Agent for external use for skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070604 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070604 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20070604 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090618 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090623 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20091020 |